Company Filing History:

6 out of 281

Glaxo Wellcome Inc.

The Lister Institute of Preventive Medicine

patents

4. 2 out of 35

University Court of the University of Dundee

patents

5. 1 out of 521

Burroughs Wellcome Co.

patents

6. 1 out of 32

The Wellcome Foundation Limited

patents

where one patent can have more than one assignee

Years Active: 1996-1999

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5980907 - Vaccines containing bacteria attenuated by mutation of the htrA gene (1999-11-09),

2. 5851519 - Live vaccines (1998-12-22),

3. 5811105 - Vaccines containing bacteria attenuated by mutations in two genes of the (1998-09-22),

4. 5804194 - Vaccines containing a salmonella bacteria attenuated by mutation of the (1998-09-08),

5. 5770214 - Vaccines containing salmonella bacteria attenuated by mutations in two (1998-06-23),

6. 5683700 - Expression of recombinant proteins in attenuated bacteria (1997-11-04),

7. 5547664 - Expression of recombinant proteins in attenuated bacteria (1996-08-20),

8. 5527529 - Vaccines comprising attenuated salmonella having mutations in the ompr (1996-06-18),

Title: The Innovations of Steven Neville Chatfield

Introduction

Steven Neville Chatfield is a prominent inventor based in Beckenham, GB. He has made significant contributions to the field of immunology, particularly through his innovative work on vaccines. With a total of eight patents to his name, Chatfield has established himself as a key figure in the development of novel approaches to vaccine technology.

Latest Patents

Among his latest patents, Chatfield has developed vaccines containing bacteria that are attenuated by mutation of the htrA gene. This invention focuses on attenuated microorganisms for use in immunoprophylaxis, where the attenuation is achieved through mutations in the DNA sequence of the microorganism. This allows the microorganism to express DNA encoding a heterologous antigen, enhancing its effectiveness as a vaccine. Another notable patent involves live vaccines, which disclose a novel method for attenuating bacteria for use in both human and animal medicine. This method specifically targets genes that regulate the expression of outer membrane proteins, particularly porin proteins.

Career Highlights

Throughout his career, Chatfield has worked with esteemed organizations such as Glaxo Wellcome Inc. and The Royal Society. His work has been instrumental in advancing vaccine technology and improving public health outcomes.

Collaborations

Some of his notable coworkers include Ian George Charles and Gordan Dougan, who have collaborated with him on various projects related to vaccine development.

Conclusion

Steven Neville Chatfield's contributions to the field of immunology through his innovative patents and collaborations have made a lasting impact on vaccine technology. His work continues to influence the development of effective vaccines for both humans and animals.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.